CIK 0001671502 · Non-accelerated filer<br>Smaller reporting company
Quoin Pharmaceuticals Ltd.
Sign in to watch- Ticker
- QNRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- Incorporated
- Israel
- Entity type
- operating
- Phone
- 703 980 4182
- Business address
- 42127 PLEASANT FOREST COURT, ASHBURN, VA, 20148-7349
- Former names
- Quoin Pharmaceuticals, Ltd., Cellect Biotechnology Ltd., Cellect Biomed Ltd.
- Open-market buys, last 90 days
- $279,966
- in 4 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$279,966. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-23 | Myers Michael Chief Executive Officer | Purchase · Series F Warrants (right to buy) | +555,556 | 555,556 | ||
| 2024-12-23 | Myers Michael Chief Executive Officer | Purchase · Series G Warrants (right to buy) | +555,556 | 555,556 | ||
| 2024-12-23 | Dunn Gordon Chief Financial Officer | Purchase | +122,221 | $0.45 | $55K | 151,077 |
| 2024-12-23 | Dunn Gordon Chief Financial Officer | Purchase · Series F Warrants (right to buy) | +122,221 | 122,221 | ||
| 2024-12-23 | Dunn Gordon Chief Financial Officer | Purchase · Series G Warrants (right to buy) | +122,221 | 122,221 | ||
| 2024-12-23 | Culverwell Anthony James Director | Purchase | +100,000 | $0.45 | $45K | 100,317 |
| 2024-12-23 | Culverwell Anthony James Director | Purchase · Series F Warrants (right to buy) | +100,000 | 100,000 | ||
| 2024-12-23 | Culverwell Anthony James Director | Purchase · Series G Warrants (right to buy) | +100,000 | 100,000 | ||
| 2024-12-09 | Cooper Joseph Patrick Director | Grant or award · Share Option (Right to Buy) | +50,714 | 50,714 | ||
| 2024-12-09 | Dunn Gordon Chief Financial Officer | Grant or award · Share Option (Right to Buy) | +338,994 | 338,994 | ||
| 2024-12-09 | Culverwell Anthony James Director | Grant or award · Share Option (Right to Buy) | +50,714 | 50,714 | ||
| 2024-12-09 | Carter Denise P. Chief Operating Officer | Grant or award · Share Option (Right to Buy) | +536,609 | 536,609 | ||
| 2024-12-09 | SEMBER MICHAEL T Director | Grant or award · Share Option (Right to Buy) | +50,714 | 50,714 | ||
| 2024-12-09 | Myers Michael Chief Executive Officer | Grant or award · Share Option (Right to Buy) | +536,603 | 536,603 | ||
| 2024-12-09 | Leong Natalie Ee Mun Director | Grant or award · Share Option (Right to Buy) | +50,714 | 50,714 | ||
| 2024-12-09 | LANGER DENNIS Director | Grant or award · Share Option (Right to Buy) | +50,714 | 50,714 | ||
| 2024-09-10 | Dunn Gordon Chief Financial Officer | Purchase | +10,000 | $0.91 | $9K | 18,856 |
| 2024-09-10 | Dunn Gordon Chief Financial Officer | Purchase | +10,000 | $0.71 | $7K | 28,856 |
| 2024-09-09 | Dunn Gordon Chief Financial Officer | Purchase | +856 | $0.80 | $685 | 856 |
| 2024-09-09 | Dunn Gordon Chief Financial Officer | Purchase | +4,000 | $0.78 | $3K | 4,856 |
Page 3 of 4 · 78 trades